Journal of Pharmaceutical Sciences & Emerging DrugsISSN: 2380-9477

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Is Hydroxychloroquine an effective drug against COVID-19?

The coronavirus (COVID-19) outbreak was declared a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 and a pandemic on 11 March 2020 by the World Health Organization (WHO). By 16 June 2020, COVID-19 has affected more than 7.82 million people worldwide and caused more than 432,000 deaths. The scientific community works relentlessly to invent vaccines, drugs and establish effective therapeutics for the COVID-19 pandemic. However, a wellknown antimalarial drug Hydroxychloroquine (HCQ) has recently received enormous attention and given an emergency use authorization from the FDA as of 3 April 2020. But, there are several concerns about the appropriate dosage and possible side effects of HCQ during COVID-19 treatment. Here we reviewed the HCQ mechanism of action against the virus and its clinical studies in COVID-19 therapy.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

GET THE APP